← Back to Search
Transmembrane Ammonium Sulfate Gradients In Liposomes Produce Efficient And Stable Entrapment Of Amphipathic Weak Bases.
G. Haran, R. Cohen, L. Bar, Y. Barenholz
Published 1993 · Chemistry, Medicine
Download PDFAnalyze on Scholarcy
Gradients of ammonium sulfate in liposomes [(NH4)2SO4]lip. > [(NH4)2SO4]med. were used to obtain 'active' loading of amphipathic weak bases into the aqueous compartment of liposomes. The loading is a result of the base exchange with the ammonium ions. This approach was applied to encapsulate anthracyclines and acridine orange inside the liposomes at very high efficiency (> 90%). Doxorubicin was accumulated in the aqueous phase of the liposomes where it reached a level as high as 100-fold the doxorubicin concentration in the remote loading medium. Most of the intraliposomal doxorubicin was present in an aggregated state. The active entrapment and loading stability were dependent on liposome lipid composition, lipid quality, medium composition and temperature, as well as on the pKa and hydrophobicity of the base. The ammonium sulfate gradient approach differs from most other chemical approaches used for remote loading of liposomes, since it neither requires preparation of the liposomes in acidic pH, nor to alkalinize the extraliposomal aqueous phase. The stability of the ammonium ion gradient is related to the low permeability of its counterion, the sulfate, which also stabilizes anthracycline accumulation for prolonged storage periods (> 6 months) due to the aggregation and gelation of anthracycline sulfate salt.
This paper references
Transport and Diffusion Across Cell Membranes
W. Stein (1986)
The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey.
T. Madden (1990)
Effects of solute concentration on the entrapment of solutes in phospholipid vesicles prepared by freeze-thaw extrusion.
C. Chapman (1991)
Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles.
L. Mayer (1985)
Light-dependent pH gradients are generated in liposomes containing ferrocyanide.
D. Deamer (1990)
Techniques for encapsulating bioactive agents into liposomes.
L. Mayer (1986)
Properties of antitumor anthracyclines and new developments in their application: Cain memorial award lecture.
F. Arcamone (1985)
Catecholamine uptake and concentration by liposomes maintaining p/ gradients.
J. Nichols (1976)
Vesicles of variable sizes produced by a rapid extrusion procedure.
L. Mayer (1986)
The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation.
G. Storm (1985)
Preparation and Characterization of Liposomal Doxorubicin for Human Use
S. Amselem (1992)
Influence of ion gradients on the transbilayer distribution of dibucaine in large unilamellar vesicles.
L. Mayer (1988)
Membrane transport of anthracyclines.
T. Skovsgaard (1982)
Pyranine (8-hydroxy-1,3,6-pyrenetrisulfonate) as a probe of internal aqueous hydrogen ion concentration in phospholipid vesicles.
N. Clement (1981)
Location and dynamics of anthracyclines bound to unilamellar phosphatidylcholine vesicles.
T. Burke (1985)
Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.
L. Mayer (1989)
Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times.
A. Gabizon (1989)
Generation of multilamellar and unilamellar phospholipid vesicles
M. Hope (1986)
Liposomes: preparation, characterization, and preservation.
D. Lichtenberg (1988)
Optimization and upscaling of doxorubicin-containing liposomes for clinical use.
S. Amselem (1990)
Gelation of liposome interior A novel method for drug encapsulation
D. Lasic (1992)
Anthracycline glycoside-membrane interactions.
E. Goormaghtigh (1984)
Hydrolysis of phosphatidylcholine in aqueous liposome dispersions
M. Grit (1989)
Structural basis of anthracycline selectivity for unilamellar phosphatidylcholine vesicles: an equilibrium binding study.
T. Burke (1985)
Principles of fluorescence spectroscopy
J. R. Lakowicz (1983)
Electronic absorption spectra and protolytic equilibria of doxorubicin: direct spectrophotometric determination of microconstants.
R. Sturgeon (1977)
Evaluation of a New Extrusion Device for the Production of Stable Oligolamellar Liposomes in a Liter Scale
S. Amselem (1989)
The influence of physical characteristics of liposomes containing doxorubicin on their pharmacological behavior.
D. Goren (1990)
In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release.
A. Horowitz (1992)
Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers.
A. Gabizon (1983)
Stability of liposomal doxorubicin formulations: Problems and prospects
Y. Barenholz (1993)
Determination of ΔpH in Chloroplasts
S. Schuldiner (1972)
Phase equilibria in the phosphatidylcholine-cholesterol system.
J. Ipsen (1987)
Novel multilayered lipid vesicles: comparison of physical characteristics of multilamellar liposomes and stable plurilamellar vesicles.
S. M. Gruner (1985)
Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential.
M. Hope (1985)
Phosphorus assay in column chromatography.
G. R. Bartlett (1959)
Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors.
L. Mayer (1990)
Permeability of lipid bilayers to water and ionic solutes.
D. Deamer (1986)
This paper is referenced by
Nanomedicines: addressing the scientific and regulatory gap
S. Tinkle (2014)
The Liposomal Formulation of Doxorubicin
W. N. (2005)
Targeting of Liposomes to Solid Tumors: The Case of Sterically Stabilized Anti-Her2 Immunoliposomes
D. Kirpotin (1997)
The fabrication of micro-porous silica structures for micro-reactor technology
P. Christensen (1998)
Characterization and in vitro evaluation of spherulites as sequestering vesicles with potential application in drug detoxification.
A. B. Dhanikula (2006)
Synthesis of a labeled RGD-lipid, its incorporation into liposomal nanoparticles, and their trafficking in cultured endothelial cells.
Sonya Cressman (2009)
A pH-Responsive Drug-Delivery Platform Based on Glycol Chitosan-Coated Liposomes.
Lesan Yan (2015)
In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach.
D. Iden (2001)
Reduction of Hepatotoxicity Induced by Doxorubicin
Dorsaf Bengaied (2017)
In vivo targeting of B-cell lymphoma with glycan ligands of CD22.
Weihsu C Chen (2010)
Development of multifunctional nanoparticles for drug delivery and bioimaging
M. Şeleci (2017)
Continuous Processing of Liposomes to Control and Predict Physical Properties
Antonio P. Costa (2016)
Development and Characterization of the Solvent-Assisted Active Loading Technology (SALT) for Liposomal Loading of Poorly Water-Soluble Compounds
Griffin Pauli (2019)
Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy.
Defu Cai (2014)
New drug candidates for liposomal delivery identified by computer modeling of liposomes' remote loading and leakage
A. Cern (2017)
An overview of clinical and commercial impact of drug delivery systems.
Aaron C. Anselmo (2014)
A novel liposomal irinotecan formulation with significant anti-tumour activity: use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention.
E. Ramsay (2008)
DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy.
K. Camacho (2016)
Enhanced anti-tumor effect of liposomal Fasudil on hepatocellular carcinoma in vitro and in vivo
Y. Zhao (2019)
Self‐assembled polypeptide nanoparticles for intracellular irinotecan delivery
N.N. Zashikhina (2017)
Nano-sized Advanced Delivery Systems as Parenteral Formulation Strategies for Hydrophobic Anti-cancer Drugs
P. Soo (2009)
Natural IgM dominates in vivo performance of liposomes.
T. Ding (2020)
Engineered liposomes bearing camptothecin analogue for tumor targeting: in vitro and ex-vivo studies.
Shivani Saraf (2020)
PHARMACY-ON-A-CHIP: MICROFLUIDIC SYNTHESIS AND PREPARATION OF TUMOR-TARGETED LIPOSOMES
R. R. Hood (2014)
From Composition to Cure: A Systems Engineering Approach to Anticancer Drug Carriers.
Sarah R MacEwan (2017)
Advances in Liposomal Drug Delivery System in the Field of Chemotherapy
Y. Hu (2016)
Manufacturing drug co-loaded liposomal formulations targeting breast cancer: influence of preparative method on liposomes characteristics and in vitro toxicity.
Leonidas Gkionis (2020)
In vivo Multiple Anticancer Drugs Immunoliposomes Significantly Enhance the Efficacy of Targeted − Epidermal Growth Factor Receptor
C. Mamot (2005)
A novel α-enolase-targeted drug delivery system for high efficacy prostate cancer therapy.
Luyao Wang (2018)
Effect of solubilizing agents on mupirocin loading into and release from PEGylated nanoliposomes.
A. Cern (2014)
Anti-CD19-Targeted Liposomal Doxorubicin Improves the Therapeutic Efficacy in Murine B-Cell Lymphoma and Ameliorates the Toxicity of Liposomes with Varying Drug Release Rates
T. Allen (2005)
Enriching lipid nanovesicles with short‐chain glucosylceramide improves doxorubicin delivery and efficacy in solid tumors
M. Lummel (2011)See more